From the publishers of JADPRO

Metastatic Triple-Negative Breast Cancer Resource Center

Advertisement

Interview with Valerie Shander, MSN, BSN, FNP, RN, AOCNP, CGRA. Clinical Trials and Pressing Clinical Questions in mTNBC

Video Interview With Anecita Fadol, PhD, FNP-BC, FAANP, FAAN, FHKAN Cardiotoxicity in Patients with mTNBC: Role of Tests, Racial Disparities, and SDOHs

Interview With Anecita Fadol, PhD, FNP-BC, FAANP, FAAN, FHKAN– Cardiotoxicity in Patients with mTNBC: Keys to Assessing and Treating It

Interview With Coral Omene, MD, PhD. Key Clinical Data in mTNBC: Updates from SABCS, Part 2

Interview With Coral Omene, MD, PhD. Key Clinical Data in mTNBC: Updates from SABCS, Part 1

Interview With Rose DiMarco, PharmD, BCPS, BCOP. Sequencing of Treatment at the Time of Relapse: A Pharmacist's Perspective

Interview With Mikel Ross, MSN, RN, AGPCNP-BC, OCN, CBCN. Practice-Changing Data in mTNBC: A Post-ASCO Update

Interview With Lindsay Shaw, ANP-BC, AOCNP: Tumor Biology and Risk Assessment in Metastatic TNBC

Interview With Sheeba Cantanelli, MPAS, PA-C: Metastatic TNBC Treatment Landscape—An Overview

Patient With Lung Metastasis and HER2-Low Status: Evolving Treatment Options

Treatment of a Patient With AML and mTNBC

Fast Facts #6: Immunotherapy and Endocrinopathies